First Time Loading...
F

Fortrea Holdings Inc
NASDAQ:FTRE

Watchlist Manager
Fortrea Holdings Inc
NASDAQ:FTRE
Watchlist
Price: 26.91 USD -2.32% Market Closed
Updated: May 21, 2024

Intrinsic Value

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. [ Read More ]

The intrinsic value of one FTRE stock under the Base Case scenario is 38.41 USD. Compared to the current market price of 26.91 USD, Fortrea Holdings Inc is Undervalued by 30%.

Key Points:
FTRE Intrinsic Value
Base Case
38.41 USD
Undervaluation 30%
Intrinsic Value
Price
F
Worst Case
Base Case
Best Case

Valuation Backtest
Fortrea Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling FTRE stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Fortrea Holdings Inc

Provide an overview of the primary business activities
of Fortrea Holdings Inc.

What unique competitive advantages
does Fortrea Holdings Inc hold over its rivals?

What risks and challenges
does Fortrea Holdings Inc face in the near future?

Has there been any significant insider trading activity
in Fortrea Holdings Inc recently?

Summarize the latest earnings call
of Fortrea Holdings Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fortrea Holdings Inc.

Provide P/S
for Fortrea Holdings Inc.

Provide P/E
for Fortrea Holdings Inc.

Provide P/OCF
for Fortrea Holdings Inc.

Provide P/FCFE
for Fortrea Holdings Inc.

Provide P/B
for Fortrea Holdings Inc.

Provide EV/S
for Fortrea Holdings Inc.

Provide EV/GP
for Fortrea Holdings Inc.

Provide EV/EBITDA
for Fortrea Holdings Inc.

Provide EV/EBIT
for Fortrea Holdings Inc.

Provide EV/OCF
for Fortrea Holdings Inc.

Provide EV/FCFF
for Fortrea Holdings Inc.

Provide EV/IC
for Fortrea Holdings Inc.

Show me price targets
for Fortrea Holdings Inc made by professional analysts.

What are the Revenue projections
for Fortrea Holdings Inc?

How accurate were the past Revenue estimates
for Fortrea Holdings Inc?

What are the Net Income projections
for Fortrea Holdings Inc?

How accurate were the past Net Income estimates
for Fortrea Holdings Inc?

What are the EPS projections
for Fortrea Holdings Inc?

How accurate were the past EPS estimates
for Fortrea Holdings Inc?

What are the EBIT projections
for Fortrea Holdings Inc?

How accurate were the past EBIT estimates
for Fortrea Holdings Inc?

Compare the revenue forecasts
for Fortrea Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fortrea Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fortrea Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fortrea Holdings Inc compared to its peers.

Compare the P/E ratios
of Fortrea Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Fortrea Holdings Inc with its peers.

Analyze the financial leverage
of Fortrea Holdings Inc compared to its main competitors.

Show all profitability ratios
for Fortrea Holdings Inc.

Provide ROE
for Fortrea Holdings Inc.

Provide ROA
for Fortrea Holdings Inc.

Provide ROIC
for Fortrea Holdings Inc.

Provide ROCE
for Fortrea Holdings Inc.

Provide Gross Margin
for Fortrea Holdings Inc.

Provide Operating Margin
for Fortrea Holdings Inc.

Provide Net Margin
for Fortrea Holdings Inc.

Provide FCF Margin
for Fortrea Holdings Inc.

Show all solvency ratios
for Fortrea Holdings Inc.

Provide D/E Ratio
for Fortrea Holdings Inc.

Provide D/A Ratio
for Fortrea Holdings Inc.

Provide Interest Coverage Ratio
for Fortrea Holdings Inc.

Provide Altman Z-Score Ratio
for Fortrea Holdings Inc.

Provide Quick Ratio
for Fortrea Holdings Inc.

Provide Current Ratio
for Fortrea Holdings Inc.

Provide Cash Ratio
for Fortrea Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Fortrea Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Fortrea Holdings Inc?

What is the current Free Cash Flow
of Fortrea Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fortrea Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fortrea Holdings Inc

Current Assets 1.3B
Cash & Short-Term Investments 108.6m
Receivables 1.1B
Other Current Assets 92.4m
Non-Current Assets 3.1B
PP&E 220.9m
Intangibles 2.8B
Other Non-Current Assets 82.7m
Current Liabilities 775.9m
Accounts Payable 132.8m
Accrued Liabilities 375.6m
Other Current Liabilities 267.5m
Non-Current Liabilities 1.8B
Long-Term Debt 1.6B
Other Non-Current Liabilities 276.6m
Efficiency

Earnings Waterfall
Fortrea Holdings Inc

Revenue
3.1B USD
Cost of Revenue
-2.6B USD
Gross Profit
520.4m USD
Operating Expenses
-433m USD
Operating Income
87.4m USD
Other Expenses
-90.8m USD
Net Income
-3.4m USD

Free Cash Flow Analysis
Fortrea Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

FTRE Profitability Score
Profitability Due Diligence

Fortrea Holdings Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive Operating Income
45/100
Profitability
Score

Fortrea Holdings Inc's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

FTRE Solvency Score
Solvency Due Diligence

Fortrea Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Low D/E
Low Altman Z-Score
44/100
Solvency
Score

Fortrea Holdings Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

FTRE Price Targets Summary
Fortrea Holdings Inc

Wall Street analysts forecast FTRE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FTRE is 41.31 USD with a low forecast of 33.33 USD and a high forecast of 47.25 USD.

Lowest
Price Target
33.33 USD
24% Upside
Average
Price Target
41.31 USD
54% Upside
Highest
Price Target
47.25 USD
76% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
Fortrea Holdings Inc

Ownership

FTRE Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

FTRE Price
Fortrea Holdings Inc

1M 1M
-24%
6M 6M
-18%
1Y 1Y
-11%
3Y 3Y
-11%
5Y 5Y
-11%
10Y 10Y
-11%
Annual Price Range
26.91
52w Low
25.11
52w High
40.28
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -33%
Shares Statistics
Market Capitalization 2.4B USD
Shares Outstanding 87 333 300
Percentage of Shares Shorted 10.68%

FTRE Return Decomposition
Main factors of price return

What is price return decomposition?

FTRE News

Other Videos

Company Profile

Fortrea Holdings Inc

Country

United States of America

Industry

Life Sciences Tools & Services

Market Cap

2.4B USD

Dividend Yield

0%

Description

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. The company is headquartered in Durham, North Carolina and currently employs 19,000 full-time employees. The company went IPO on 2023-06-16. The firm is a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services. The Company’s segments include Clinical Services and Enabling Services. The Company’s global solutions include Clinical Development, Clinical Pharmacology, Drug Development Consulting Services, Device and Diagnostic Development, and Full and Functional Service Provider Models, among others. Its Clinical Development solutions include Early: Phase I/II a, Late: Phase II b/III, Real-World Evidence and Post-Approval Studies, Decentralized Clinical Trials, Data Analysis and Reporting, Clinical Trial Project Management and Monitoring, and Patient Safety and Pharmacovigilance. By therapeutic or specialty areas, it has scientific expertise in cardiovascular, cell and gene therapies, dermatology, diabetes and endocrinology, hepatology, infectious disease, and others.

Contact

NORTH CAROLINA
Durham
8 Moore Drive
+18774950816

IPO

2023-06-16

Employees

19 000

Officers

CEO, President & Chairman
Mr. Thomas H. Pike
Chief Financial Officer
Ms. Jill McConnell
COO & President of Clinical Services
Mr. Mark A. Morais
Chief Accounting Officer
Amanda M. Warren
Head of Investor Relations & Corporate Development
Ms. Hima B. Inguva
General Counsel & Corporate Secretary
Stillman Hanson
Show More
President of Consulting
Dr. John J. Doyle
Show Less

See Also

Discover More
What is the Intrinsic Value of one FTRE stock?

The intrinsic value of one FTRE stock under the Base Case scenario is 38.41 USD.

Is FTRE stock undervalued or overvalued?

Compared to the current market price of 26.91 USD, Fortrea Holdings Inc is Undervalued by 30%.